查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945318

2026年全球荷尔蒙子宫内避孕器（IUD）市场报告

Hormonal Intrauterine Devices (IUDs) Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，含激素子宫内避孕器（IUD）市场发展迅速，预计将从2025年的28.7亿美元成长到2026年的31.8亿美元，复合年增长率达10.6%。这一增长可归因于人们对计划生育选择的认识不断提高、女性生殖健康项目的扩展、对长期避孕方式的偏好日益增长、含激素节育器的普及以及公共卫生倡议的支持。

预计未来几年，含激素子宫内避孕器（IUD）市场将快速成长，到2030年市场规模将达到47.4亿美元，复合年增长率（CAGR）为10.5%。预测期内的成长要素包括：非手术避孕需求不断增长、对月经健康管理的关注度日益提高、新兴市场准入范围扩大、对女性健康技术的投资增加以及激素输送系统的不断创新。预测期内的主要趋势包括：低剂量含激素子宫内避孕器的使用率不断提高、对长效可逆避孕方法（LARC）的需求不断增长、对无框架避孕器的偏好日益增强、治疗性子宫内避孕器的应用范围扩大以及对患者舒适度和安全性的日益重视。

预计未来几年，意外怀孕的增加将推动含激素子宫内避孕器（IUD）市场的成长。意外怀孕是指在受孕时没有计划或意愿的怀孕。原因多种多样，包括避孕失败、避孕措施匮乏、避孕措施滥用、性侵犯。有效避孕措施的匮乏限制了个人的生育选择，从而增加了意外怀孕的可能性。含激素子宫内避孕器在预防怀孕方面非常有效，失败率低于1%。根据类型不同，它们可提供三至七年的长期保护，是希望避免意外怀孕人士的可靠选择。例如，据总部位于美国的专业组织「家庭计画协会」称，美国堕胎数量从2023年的105万例增加到2024年的114万例。因此，意外怀孕的增加推动了对含激素子宫内避孕器的需求。

荷尔蒙子宫内避孕器市场的主要企业致力于开发先进的解决方案，例如levonorgestrel子宫内避孕器（IUD），它有助于减少月经出血和月经经痛。levonorgestrel子宫内避孕器是一种长效避孕装置，放置于子宫内。它透过逐渐释放levonorgestrel来预防怀孕。例如，2024年10月，总部位于美国的非营利组织Medicines360在尚比亚推出了52毫克levonorgestrel子宫内避孕器「Avibela」。本产品具有双重功效：长达八年的避孕效果和长达五年的缓解月经过多。其避孕作用是透过增稠子宫颈黏液，阻止精子进入子宫来实现的；而其治疗作用则是透过使子宫内膜变薄来减少月经量。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球荷尔蒙子宫内避孕器（IUD）市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 永续性、气候技术和循环经济
    • 人工智慧（AI）和自主人工智慧
  • 主要趋势
    • 低剂量荷尔蒙子宫内避孕器使用率不断提高
    • 对长效可逆避孕法的需求不断增长
    • 人们越来越喜欢无边框设备
    • 扩大治疗性子宫内避孕器的适应症
    • 更重视患者的舒适度与安全性

第五章 终端用户产业市场分析

  • 医院
  • 妇科诊所
  • 计划生育诊所
  • 生殖健康中心
  • 门诊治疗中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球荷尔蒙子宫内避孕器（IUD）市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球荷尔蒙子宫内避孕器（IUD）市场规模、对比及成长率分析
  • 全球荷尔蒙子宫内避孕器（IUD）市场表现：规模与成长，2020-2025年
  • 全球荷尔蒙子宫内避孕器（IUD）市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按类型
  • 13毫克激素子宫内避孕器、19毫克激素子宫内避孕器、52毫克激素子宫内避孕器
  • 透过设备设计
  • 有框架子宫内避孕器，无框架子宫内避孕器
  • 依激素类型
  • levonorgestrel子宫内避孕器，黄体素子宫内避孕器
  • 透过使用
  • 年龄范围：20-24岁、25-34岁、35-44岁等用途
  • 按类型细分：13毫克激素子宫内避孕器
  • 低剂量 13 毫克子宫内避孕器，特殊用途 13 毫克子宫内避孕器
  • 按类型细分：19毫克激素子宫内避孕器
  • 低剂量 19 毫克子宫内避孕器，特殊用途 19 毫克子宫内避孕器
  • 按类型细分：52毫克激素子宫内避孕器
  • 标准型 52 毫克子宫内避孕器、缓释型 52 毫克子宫内避孕器以及用于治疗月经过多或子宫内膜异位症的特殊型 52 毫克子宫内避孕器

第十章 区域与国家分析

  • 全球荷尔蒙子宫内避孕器（IUD）市场：区域分析、预测与展望（2020-2025年、2025-2030年、2035年）。
  • 全球荷尔蒙子宫内避孕器（IUD）市场：国家、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 荷尔蒙子宫内避孕器（IUD）市场：竞争格局与市场份额，2024年
  • 荷尔蒙子宫内避孕器（IUD）市场：公司估值矩阵
  • 荷尔蒙子宫内避孕器（IUD）市场：公司概况
    • Bayer AG
    • Organon & Companies
    • Gedeon Richter Plc
    • Meril Life Science Pvt Ltd.
    • Teva UK Limited

第37章：其他领先和创新企业

  • Medicines360, HLL Lifecare Limited, Pregna International Ltd., DKT WomanCare Global, SMB Corporation of India, Oy Leiras, OCON Healthcare, Bayer Healthcare Pharmaceuticals, CooperSurgical Inc., Mithra Pharmaceuticals, Shanghai Dahua Medical Apparatus Co. Ltd., Beijing Zizhu Pharmaceutical Co. Ltd., Shanghai Jiansheng Medical Devices Co. Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Shanghai Chuangling Medical Devices Co. Ltd.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年荷尔蒙子宫内避孕器（IUD）市场：提供新机会的国家
  • 2030年荷尔蒙子宫内避孕器（IUD）市场：充满新机会的细分市场
  • 2030年荷尔蒙子宫内避孕器（IUD）市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MHIDI01_G26Q1

Hormonal intrauterine devices (IUDs) are small, T-shaped plastic devices that are inserted into the uterus and release progestin, a synthetic hormone. These devices prevent pregnancy by thickening cervical mucus to block sperm, thinning the uterine lining to impede implantation, and sometimes suppressing ovulation. Additionally, they can reduce menstrual bleeding and cramping, and in some cases, may stop periods altogether.

The primary types of hormonal IUDs include 13-milligram, 19-milligram, and 52-milligram hormonal IUDs. The 13-milligram hormonal IUDs, which release a low dose of hormones for up to three years, are becoming increasingly popular among women seeking long-acting contraceptive options with lower hormone exposure. The design of these devices varies, including framed and frameless IUDs, and they feature different hormone types such as levonorgestrel-releasing and progesterone-releasing IUDs. These options cater to various age groups, including those aged 20-24, 25-34, and 35-44, among other applications.

Tariffs are impacting the hormonal intrauterine devices market by increasing costs of imported medical-grade polymers, hormone compounds, packaging materials, and precision manufacturing equipment. Healthcare providers in North America and Europe are most affected due to reliance on imported device components, while Asia-Pacific faces pricing pressure on export-oriented production. These tariffs are contributing to higher device procurement costs and slower market penetration in cost-sensitive regions. However, they are also encouraging localized manufacturing, regional supply chain development, and domestic production of hormonal IUDs.

The hormonal intrauterine devices (iuds) market research report is one of a series of new reports from The Business Research Company that provides hormonal intrauterine devices (iuds) market statistics, including hormonal intrauterine devices (iuds) industry global market size, regional shares, competitors with a hormonal intrauterine devices (iuds) market share, detailed hormonal intrauterine devices (iuds) market segments, market trends and opportunities, and any further data you may need to thrive in the hormonal intrauterine devices (iuds) industry. This hormonal intrauterine devices (iuds) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hormonal intrauterine devices (iuds) market size has grown rapidly in recent years. It will grow from $2.87 billion in 2025 to $3.18 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to increasing awareness of family planning options, expansion of women's reproductive healthcare programs, rising preference for long-term contraception, availability of hormone-based devices, support from public health initiatives.

The hormonal intrauterine devices (iuds) market size is expected to see rapid growth in the next few years. It will grow to $4.74 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increasing demand for non-surgical contraceptive solutions, rising focus on menstrual health management, expansion of access in emerging markets, growing investments in women's health technologies, increasing innovation in hormone delivery systems. Major trends in the forecast period include increasing adoption of low-dose hormonal iuds, rising demand for long-acting reversible contraceptives, growing preference for frameless device designs, expansion of therapeutic iud applications, enhanced focus on patient comfort and safety.

The rise in unwanted pregnancies is expected to drive the growth of the hormonal intrauterine devices (IUDs) market in the coming years. Unwanted pregnancies are those that occur without planning or desire at the time of conception. They can result from various factors, including contraceptive failure, limited access to birth control, incorrect use of contraception, or sexual violence. Restricted access to effective contraception increases the likelihood of unwanted pregnancies by limiting individuals' control over their reproductive choices. Hormonal IUDs are highly effective in preventing pregnancy, with a failure rate below 1%. They offer long-term protection, ranging from three to seven years depending on the type, making them a dependable option for individuals seeking to avoid unwanted pregnancies. For example, according to the Society for Family Planning, a US-based professional organization, abortions in the United States rose to 1.14 million in 2024, up from 1.05 million in 2023. Consequently, the increase in unwanted pregnancies is propelling the demand for hormonal IUDs.

Major companies in the hormonal intrauterine devices market are focusing on developing advanced solutions, such as levonorgestrel IUDs, which help reduce menstrual bleeding and cramps. Levonorgestrel IUDs are long-term contraceptive devices inserted into the uterus that gradually release the hormone levonorgestrel to prevent pregnancy. For instance, in October 2024, Medicines360, a US-based nonprofit organization, launched Avibela, a 52 mg levonorgestrel IUD, in Zambia. It provides dual benefits: up to eight years of pregnancy prevention and up to five years of relief from heavy menstrual bleeding. Its contraceptive effect is achieved by thickening cervical mucus to block sperm from reaching the uterus, while its therapeutic effect reduces menstrual flow by thinning the uterine lining.

In January 2024, Medicines360 partnered with DKT WomanCare Global to expand the accessibility of the affordable hormonal IUD Avibela. This collaboration aimed to increase awareness and reach, particularly in underserved regions, improving global sexual and reproductive health. DKT WomanCare Global, a France-based organization, focuses on enhancing the availability, accessibility, and affordability of sexual and reproductive health products for women.

Major companies operating in the hormonal intrauterine devices (iuds) market are Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Teva UK Limited, Medicines360, HLL Lifecare Limited, Pregna International Ltd., DKT WomanCare Global, SMB Corporation of India, Oy Leiras, OCON Healthcare, Bayer Healthcare Pharmaceuticals, CooperSurgical Inc., Mithra Pharmaceuticals, Shanghai Dahua Medical Apparatus Co. Ltd., Beijing Zizhu Pharmaceutical Co. Ltd., Shanghai Jiansheng Medical Devices Co. Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Shanghai Chuangling Medical Devices Co. Ltd.

North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (iuds) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hormonal intrauterine devices (iuds) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hormonal intrauterine devices (IUDs) market consists of sales of hormone reservoir, strings, and insertion or removal instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hormonal Intrauterine Devices (IUDs) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses hormonal intrauterine devices (iuds) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hormonal intrauterine devices (iuds) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hormonal intrauterine devices (iuds) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: 13 Milligram Hormonal Intrauterine Devices; 19 Milligram Hormonal Intrauterine Devices; 52 Milligram Hormonal Intrauterine Devices
  • 2) By Device Design: Framed Intrauterine Devices; Frameless Intrauterine Devices
  • 3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices; Progesterone Releasing Intrauterine Devices
  • 4) By Application: Age 20-24; Age 25-34; Age 35-44; Other Applications
  • Subsegments:
  • 1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs; Specialty 13 Mg IUDs For Specific Conditions
  • 2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs; Specialty 19 Mg IUDs For Specific Conditions
  • 3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs; Extended-Release 52 Mg IUDs; Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis
  • Companies Mentioned: Bayer AG; Organon & Companies; Gedeon Richter Plc; Meril Life Science Pvt Ltd.; Teva UK Limited; Medicines360; HLL Lifecare Limited; Pregna International Ltd.; DKT WomanCare Global; SMB Corporation of India; Oy Leiras; OCON Healthcare; Bayer Healthcare Pharmaceuticals; CooperSurgical Inc.; Mithra Pharmaceuticals; Shanghai Dahua Medical Apparatus Co. Ltd.; Beijing Zizhu Pharmaceutical Co. Ltd.; Shanghai Jiansheng Medical Devices Co. Ltd.; Zhejiang Xianju Pharmaceutical Co. Ltd.; Shanghai Chuangling Medical Devices Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Hormonal Intrauterine Devices (IUDs) Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Hormonal Intrauterine Devices (IUDs) Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Hormonal Intrauterine Devices (IUDs) Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Hormonal Intrauterine Devices (IUDs) Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Sustainability, Climate Tech & Circular Economy
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Low-Dose Hormonal Iuds
    • 4.2.2 Rising Demand For Long-Acting Reversible Contraceptives
    • 4.2.3 Growing Preference For Frameless Device Designs
    • 4.2.4 Expansion Of Therapeutic Iud Applications
    • 4.2.5 Enhanced Focus On Patient Comfort And Safety

5. Hormonal Intrauterine Devices (IUDs) Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Gynecology Clinics
  • 5.3 Family Planning Clinics
  • 5.4 Reproductive Health Centers
  • 5.5 Ambulatory Care Centers

6. Hormonal Intrauterine Devices (IUDs) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Hormonal Intrauterine Devices (IUDs) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Hormonal Intrauterine Devices (IUDs) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Hormonal Intrauterine Devices (IUDs) Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Hormonal Intrauterine Devices (IUDs) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Hormonal Intrauterine Devices (IUDs) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Hormonal Intrauterine Devices (IUDs) Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Hormonal Intrauterine Devices (IUDs) Market Segmentation

  • 9.1. Global Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 13 Milligram Hormonal Intrauterine Devices, 19 Milligram Hormonal Intrauterine Devices, 52 Milligram Hormonal Intrauterine Devices
  • 9.2. Global Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Framed Intrauterine Devices, Frameless Intrauterine Devices
  • 9.3. Global Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Levonorgestrel Releasing Intrauterine Devices, Progesterone Releasing Intrauterine Devices
  • 9.4. Global Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Age 20-24, Age 25-34, Age 35-44, Other Applications
  • 9.5. Global Hormonal Intrauterine Devices (IUDs) Market, Sub-Segmentation Of 13 Milligram Hormonal Intrauterine Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Low-Dose 13 Mg IUDs, Specialty 13 Mg IUDs For Specific Conditions
  • 9.6. Global Hormonal Intrauterine Devices (IUDs) Market, Sub-Segmentation Of 19 Milligram Hormonal Intrauterine Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Low-Dose 19 Mg IUDs, Specialty 19 Mg IUDs For Specific Conditions
  • 9.7. Global Hormonal Intrauterine Devices (IUDs) Market, Sub-Segmentation Of 52 Milligram Hormonal Intrauterine Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Standard 52 Mg IUDs, Extended-Release 52 Mg IUDs, Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis

10. Hormonal Intrauterine Devices (IUDs) Market Regional And Country Analysis

  • 10.1. Global Hormonal Intrauterine Devices (IUDs) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Hormonal Intrauterine Devices (IUDs) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market

  • 11.1. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Hormonal Intrauterine Devices (IUDs) Market

  • 12.1. China Hormonal Intrauterine Devices (IUDs) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Hormonal Intrauterine Devices (IUDs) Market

  • 13.1. India Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Hormonal Intrauterine Devices (IUDs) Market

  • 14.1. Japan Hormonal Intrauterine Devices (IUDs) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Hormonal Intrauterine Devices (IUDs) Market

  • 15.1. Australia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Hormonal Intrauterine Devices (IUDs) Market

  • 16.1. Indonesia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Hormonal Intrauterine Devices (IUDs) Market

  • 17.1. South Korea Hormonal Intrauterine Devices (IUDs) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Hormonal Intrauterine Devices (IUDs) Market

  • 18.1. Taiwan Hormonal Intrauterine Devices (IUDs) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Hormonal Intrauterine Devices (IUDs) Market

  • 19.1. South East Asia Hormonal Intrauterine Devices (IUDs) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Hormonal Intrauterine Devices (IUDs) Market

  • 20.1. Western Europe Hormonal Intrauterine Devices (IUDs) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Hormonal Intrauterine Devices (IUDs) Market

  • 21.1. UK Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Hormonal Intrauterine Devices (IUDs) Market

  • 22.1. Germany Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Hormonal Intrauterine Devices (IUDs) Market

  • 23.1. France Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Hormonal Intrauterine Devices (IUDs) Market

  • 24.1. Italy Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Hormonal Intrauterine Devices (IUDs) Market

  • 25.1. Spain Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market

  • 26.1. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Hormonal Intrauterine Devices (IUDs) Market

  • 27.1. Russia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Hormonal Intrauterine Devices (IUDs) Market

  • 28.1. North America Hormonal Intrauterine Devices (IUDs) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Hormonal Intrauterine Devices (IUDs) Market

  • 29.1. USA Hormonal Intrauterine Devices (IUDs) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Hormonal Intrauterine Devices (IUDs) Market

  • 30.1. Canada Hormonal Intrauterine Devices (IUDs) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Hormonal Intrauterine Devices (IUDs) Market

  • 31.1. South America Hormonal Intrauterine Devices (IUDs) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Hormonal Intrauterine Devices (IUDs) Market

  • 32.1. Brazil Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Hormonal Intrauterine Devices (IUDs) Market

  • 33.1. Middle East Hormonal Intrauterine Devices (IUDs) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Hormonal Intrauterine Devices (IUDs) Market

  • 34.1. Africa Hormonal Intrauterine Devices (IUDs) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Hormonal Intrauterine Devices (IUDs) Market Regulatory and Investment Landscape

36. Hormonal Intrauterine Devices (IUDs) Market Competitive Landscape And Company Profiles

  • 36.1. Hormonal Intrauterine Devices (IUDs) Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Hormonal Intrauterine Devices (IUDs) Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Hormonal Intrauterine Devices (IUDs) Market Company Profiles
    • 36.3.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Organon & Companies Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Gedeon Richter Plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Meril Life Science Pvt Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Teva UK Limited Overview, Products and Services, Strategy and Financial Analysis

37. Hormonal Intrauterine Devices (IUDs) Market Other Major And Innovative Companies

  • Medicines360, HLL Lifecare Limited, Pregna International Ltd., DKT WomanCare Global, SMB Corporation of India, Oy Leiras, OCON Healthcare, Bayer Healthcare Pharmaceuticals, CooperSurgical Inc., Mithra Pharmaceuticals, Shanghai Dahua Medical Apparatus Co. Ltd., Beijing Zizhu Pharmaceutical Co. Ltd., Shanghai Jiansheng Medical Devices Co. Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Shanghai Chuangling Medical Devices Co. Ltd.

38. Global Hormonal Intrauterine Devices (IUDs) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Hormonal Intrauterine Devices (IUDs) Market

40. Hormonal Intrauterine Devices (IUDs) Market High Potential Countries, Segments and Strategies

  • 40.1 Hormonal Intrauterine Devices (IUDs) Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Hormonal Intrauterine Devices (IUDs) Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Hormonal Intrauterine Devices (IUDs) Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer